The document discusses the role of artificial intelligence (AI) in enhancing data quality assurance in clinical trials, emphasizing its importance for data accuracy, regulatory compliance, and patient safety. It highlights various AI technologies and methods such as automated data validation, real-time monitoring, and predictive analytics that improve the efficiency and reliability of clinical trials. Additionally, the document addresses challenges such as data quality, ethical concerns, and integration with existing systems but concludes that AI presents significant opportunities for advancing medical research.